BluePath Capital LLC – Trademark Portfolio
Entity Type: 16
BluePath Capital LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ANNUITYUSA and NICHOLAS WEALTH MANAGEMENT. The owner is based in Atlanta, GA.
2859 Paces Ferry Road, Suite 420
Atlanta, GA 30339
Showing of trademarks Trademarks
Trademark Classifications
BluePath Capital LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does BluePath Capital LLC have?
BluePath Capital LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does BluePath Capital LLC file in?
BluePath Capital LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are BluePath Capital LLC's most well-known trademarks?
BluePath Capital LLC's registered trademark portfolio includes well-known marks such as ANNUITYUSA and NICHOLAS WEALTH MANAGEMENT. These are among 2 currently registered trademarks in the portfolio.
What is BluePath Capital LLC's trademark registration success rate?
BluePath Capital LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.